pegargiminase,Pemetrexed,Cisplatin
polaris pharma
['pegargiminase', 'mesothelioma', 'lioi']
adding pegargiminase to standard frontline chemotherapy improves outcomes in patients with nonepithelioid pleural mesothelioma, a phase 2/3 study presented at aacr 2023 suggests. #aacr23 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.